FDA Elsa 4.0 AI deployment still hallucinating after rollout, and what it means for AI reliability evaluation in high-stakes systems
The FDA Is Using an AI That Hallucinates. On Drug Reviews. Let me say that plainly before anything else: the Food and Drug Administration, the agency responsible for deciding which drugs are safe for 330 million Americans, rolled out an AI assistant in May 2026 that its own reviewers describe as “clunky” and that still…
